Merger Notification - Announcement according to § 10 Cartel Act
Edwards Lifesciences Corporation; JenaValve Technology, Inc
BWB/Z-6717
On 12.09.2024 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Edwards Lifesciences Corporation (USA) intends to acquire, by means of a merger between JenaValve Technology, Inc. (USA) and a wholly-owned subsidiary of Edwards Lifesciences Corporation, all shares in, and sole control of, JenaValve Technology, Inc.
The transaction concerns medical devices for use in heart diseases (mechanical heart valves).
C - MANUFACTURING
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 24.10.2024.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
On October the 8th 2024 the applicant requested the extension of the deadline for the submission of an application for examination by two weeks, pursuant to § 11 (1a) Cartel Act. The deadline for the submission of an application for examinations by the administrative authorities is extended by two weeks, thus ending on October the 24th 2024.